Actual Incidence and Clinical Behaviour of Follicular Thyroid Carcinoma: An Institutional Experience

Table 1

Clinical, pathological, and follow-up data of all the included patients. Comparative analysis between MI-FTC and WI-FTC.

	All patients	MI-FTC	WI-FTC	𝑃 value
Patients	130	66	64
Age (±SD^a) (range) years	51.1±14.5 (18–88)	50.0±11.6 (28–76)	52.3±9.9 (18–88)	NS*
Male/female	39/91	15/51	24/40	NS*
Tumour size (± SD^a) (range) mm	28.9±16.6 (5–100)	23.1±13.0 (5–70)	35.1±17.8 (11–100)	<0.001
Distant metastasis at diagnosis	4	1	3	NS*
pT stage
T1/T2/T3	36/63/31	27/33/6	9/30/25	<0.001
pT1	36	27	9	<0.001
pT2	63	33	30	NS*
pT3	31	6	25	<0.001
pN stage
NX/N0/N1	129/0/1	66/0/0	63/0/1	NS*
pM stage
M0/M1	126/4	65/1	61/3	NS*
Multifocal disease	4	2	2	NS*
Microcarcinoma	7	5	2	NS*
HCC	63	25	38	<0.05
Concomitant PTC	21	15	6	NS*
Follow-up yes/no	117/13	62/4	55/9	NS*
Follow-up (±SD^a) (range) months	103.9±39.5 (17–182)	95.5±111.0 (17–174)	104.5±109.5 (27–182)	NS*
RAI/no RAI	105/12	54/8	51/3	NS*
Distant metastasis at follow-up	3	0	3	NS*

SD^a: standard deviation; NS*: not significant.